| CTRI Number |
CTRI/2024/10/075876 [Registered on: 25/10/2024] Trial Registered Prospectively |
| Last Modified On: |
23/10/2024 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Drug Ayurveda Physiotherapy (Not Including YOGA) Other (Specify) [Marma therapy ] |
| Study Design |
Randomized, Parallel Group Trial |
|
Public Title of Study
|
To Evaluate the Response of Etipathogenesis Based Marma Therapy on Spastic Cerebral Palsy Patients and
To Design a Project on Wellequipped Center of Neurological Disorders
|
|
Scientific Title of Study
|
To Evaluate the Response of Etipathogenesis Based Marma Therapy on Spastic Cerebral Palsy Patients and To Design a Project on Well-equipped Center of Neurological Disorders
|
| Trial Acronym |
|
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Prof BM singh |
| Designation |
Professor |
| Affiliation |
Institute of medical sciences, BHU |
| Address |
department of Kaumarbhritya/Bal Roga, Faculty of Ayurveda, IMS, BHU, Varanasi, India
Varanasi UTTAR PRADESH 221005 India |
| Phone |
9415286910 |
| Fax |
|
| Email |
bms@bhu.ac.in |
|
Details of Contact Person Scientific Query
|
| Name |
Prof BM Singh |
| Designation |
professor |
| Affiliation |
Institute of medical sciences, BHU |
| Address |
department of Kaumarbhritya/Bal Roga, Faculty of Ayurveda, IMS, BHU, Varanasi, India
Varanasi UTTAR PRADESH 221005 India |
| Phone |
9415286910 |
| Fax |
|
| Email |
bms@bhu.ac.in |
|
Details of Contact Person Public Query
|
| Name |
Shree Devvrat ji |
| Designation |
Scholar |
| Affiliation |
Institute of medical sciences, BHU |
| Address |
department of Kaumarbhritya/Bal Roga, Faculty of Ayurveda, IMS, BHU, Varanasi, India
Varanasi UTTAR PRADESH 221005 India |
| Phone |
7037309005 |
| Fax |
|
| Email |
shreedevvratji@gmail.com |
|
|
Source of Monetary or Material Support
|
| Monetary by Proff.B.M.Singh,Sir Sunderlal Hospital,Institute of Medical Sciences, Banaras Hindu
University, Varanasi, 221005, Uttar Pradesh, India |
|
|
Primary Sponsor
|
| Name |
Banaras Hindu University |
| Address |
Sir Sunderlal Hospital,Institute of Medical Sciences, Banaras Hindu
University, Varanasi, 221005, Uttar Pradesh, India |
| Type of Sponsor |
Research institution and hospital |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Prof Bm Singh |
Sir sunderlal hospital ims, bhu |
OPD no 25 Department of Kaumarbhritya/Bal Roga, Faculty of Ayurveda, IMS, BHU, Varanasi, India Varanasi UTTAR PRADESH |
09415286910
bms@bhu.ac.in |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional Ethics committe, Insitute of medical sciences, Banaras Hindu University,Varanshi |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition:G00-G99||Diseases of the nervous system. Ayurveda Condition: VATAVYADHIH, |
|
|
Intervention / Comparator Agent
|
| sno | Intervention/Comparator | Type | Drug-Type | Procedure Name | Details | | 1 | Intervention Arm | Procedure | - | marmacikitsA, मरà¥à¤®à¤šà¤¿à¤•ितà¥à¤¸à¤¾ | (Procedure Reference: Sushrut sharir 6, Procedure details: Out of 107 Marma, the following important Marma points are considered for the evaluation of quadriplegic CP cases.
1. Sthapni Marma, 2. Shringataka Marma, 3. Maniobandh Marma, 4. Amsa Marma, 5. Ani Marma 6. Apalapa Marma, 7. Gulph Marma, 8. Simanta Marma.Perform the massage motion in a clockwise motion forward from right to left as it started from 12 to 1, 2, 3 & so on, & counterclockwise manner backward from left to right to left from 12 to 11, 10, 9 & so on.)
| | 2 | Comparator Arm | Procedure | - | aBya~ggaH, अà¤à¥à¤¯à¤‚ग | (Procedure Reference: Charak sutrasthana , Procedure details: Medicated Oil application on whole body followed by swedana karma & basti karma)
|
|
|
|
Inclusion Criteria
|
| Age From |
6.00 Month(s) |
| Age To |
16.00 Year(s) |
| Gender |
Both |
| Details |
cerebral palsy patient specialy spastic cerebral palsy patient |
|
| ExclusionCriteria |
| Details |
children suffering from any acute life-threatening illness
any congenital malformation or genetic disorder |
|
|
Method of Generating Random Sequence
|
Coin toss, Lottery, toss of dice, shuffling cards etc |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Participant Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
GMFCS Level Assessment
Goniometer Assessment
Language Milestone
Investigation as per IPD protocol |
At registration 15th day and after 1 month of registration |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| To improve quality of life & reduce spasticity |
At registration 15th day & 1 month after registration |
|
|
Target Sample Size
|
Total Sample Size="20" Sample Size from India="20"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
03/11/2024 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="0" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
Marma therapy is an ancient therapy describe in our ayurvedic text of Samhitta. In ayurveda text 107 Marma point describe .In this trial i choose some special Marma to reduce the spasticity or improve the quality of life cerebral palsy patient. |